The Softgel Capsules Market shows a steady expansion outlook during 2025 to 2035 because consumers want easy-to-ingest drugs and dietary supplements and pharmaceutical companies keep advancing their products.
Due to their tamper-proof design and smooth texture and improved drug absorption softgel capsules serve daily vitamins and supplements and prescription medication needs. Business insights indicate that the market will generate USD 1,235.9 million in revenue during 2025 before reaching USD 2,172 million by 2035 with a prospective compound annual growth rate (CAGR) of 5.8%.
Market growth occurs because populations age more rapidly while healthcare consciousness expands along with consumer enthusiasm for nutraceuticals. Product variety gains strength through technological innovation which provides vegan and plant-based gelatin alternatives for encapsulation methods.
The market adoption of these products is likely to face limitations because of production costs, regulatory hurdles and ingredient reactions to both moisture and temperature conditions. Ören manufacturers resolve such challenges through both optimized production line management and the creation of recipe solutions that work well for sensitive materials.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 1,235.9 million |
| Industry Value (2035F) | USD 2,172 million |
| CAGR (2025 to 2035) | 5.8% |
The Softgel Capsules Market segments according to type and application because pharmaceuticals and dietary supplement market interests are expanding. The two major softgel classifications are gelatin-based and non-gelatin (vegetarian) versions. The majority of capsules follow the gelatin-based design since it remains the industry standard for manufacturing whereas vegan consumers prefer non-gelatin alternatives.
The dietary supplement segment dominates the Softgel Capsules market because users actively seek wellness solutions and nutritional support for their immunity. Drugs have increasingly become important pharmaceutical products because they provide a delivery method for lipid-soluble medications. Hi-tech healthcare trends drive manufacturing companies to develop precise softgel medications that meet the requirements of unique medical needs and life cycle timing for different age segments.
Explore FMI!
Book a free demo
North America is estimated to hold a commanding share of the softgel capsules market due to high usage of nutritional supplements, strong pharmaceutical investment in R&D, and preference toward innovative oral drug delivery solution. In terms of leadership in demand and innovation, the USA and Canada take the first places.
Increasing health consciousness, favourable regulatory framework for nutraceuticals and rising demand for vegan and organic formulations also drive the market for Europe. Germany, France, and the UK lead growth driven by premium supplement lines & growing integral to pharmacy distribution
The softgel capsules market demand is fastest growing in the Asia-Pacific area, owing to increasing middle-class incomes, better access to health care, and a growing interest in preventive health in the region. When you say China, India, Japan, South Korea, just to invest in supplement manufacturing and consumer education campaigns.
Challenge: High Production Costs and Material Sensitivities
In contrast, softgels need the use of specialized encapsulation machinery, stringent temperature and humidity controls, and a high degree of precision with gelatin or plant-based polymers. These challenging conditions result in higher operational costs, hence contract manufacturing and in-house production become on the capital-intensive side.
Moreover, softgels are sensitive to moisture, oxygen, and heat, which can cause product instability especially in design nutraceuticals or pharmaceuticals containing volatile oils, live probiotics, or lipid-soluble compounds. The growing number of vegetarian diets worldwide, for example, poses an additional challenge to the softgel form, as gelatin is unsuitable for certain consumer bases (e.g. vegetarians, vegans, and certain religious populations).
Opportunity: Growth in Nutraceuticals, Personalized Dosing, and Plant-Based Alternatives
Despite these limitations, the global softgel capsules market is expected to witness significant growth due to the rising demand for nutraceuticals, omega-3 dietary supplements, herbal extracts, and disease-specific formulations. It provides many benefits, such as convenient swallowing, fast bioavailability, and higher stability of oil-based compounds. Softgels are preferred by consumers for vitamins, anti-inflammatory blends, joint support and cognitive health, driving demand for end-users of all ages.
Vegetarian softgel shells contain tapioca starch, carrageenan or modified cellulose, which has given rise to plant-based supplement brands. In medicine, they are increasingly being used in controlled-release systems, pediatric formulations, and hormonal therapies due to their customizable dosage and taste-masking capabilities.
The period between 2020 and 2024 experienced consistent growth in the softgel capsules market as the rising concern for health and demand for easy-to-consume delivery formats began to augment the market. The new format led many nutraceutical brands into turmeric, fish oil, CBD, and coenzyme Q10 softgels and pharmaceutical companies began investigating softgel technology for hormonal and gastrointestinal drugs. But animal-derived gelatin's prevalence and regulatory challenges related to dosage precision and labelling presented barriers.
Between 2025 to 2035, clean-label, bioavailable, and personalized softgel solutions will dominate the market. Emerging technologies will create a future of dual-fill capsules, microencapsulation, and delayed-release coatings that allow for the multi-phase or targeted delivery of active ingredients.
Innovations in plant-based gelatin alternatives, biodegradable shells, and allergen-free formulations will boost appeal with diverse dietary preferences. This smart packaging combined with digital integration will allow for trackable dosing and e-commerce distribution, including subscription-based supplement plans. The competitive landscape of the market will expand even further as pharmaceutical companies adopt softgel systems for orally delivered vaccines, oncology drugs, and long-acting therapeutics.
Market Shifts: A Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Shift | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Emphasis on labelling accuracy, gelatin sourcing, and potency testing. |
| Technological Advancements | Focused on single-fill oil-based formulations with gelatin shells. |
| Sustainability Trends | Early interest in vegetarian alternatives and low-waste production. |
| Market Competition | Dominated by nutritional supplement companies and contract manufacturers. |
| Industry Adoption | Common in vitamins, herbal extracts, and omega-3 oils. |
| Consumer Preferences | Favourable for easy swallowing and high absorption formats. |
| Market Growth Drivers | Growth driven by nutraceutical demand and user-friendly formats. |
| Market Shift | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Expansion into plant-based compliance, controlled-release approval, and cross-border nutraceutical labelling. |
| Technological Advancements | Growth in dual-fill softgels, delayed-release formats, and starch-based encapsulation. |
| Sustainability Trends | Broad shift to biodegradable capsules, eco-certified manufacturing, and zero- gelatin solutions. |
| Market Competition | Entry of clean-label startups, pharmaceutical innovators, and personalized wellness brands. |
| Industry Adoption | Expanded into oral biologics, condition-specific formulations, and digital health-linked dosing. |
| Consumer Preferences | Preference for plant-based, allergen-free, customized softgels with traceable ingredients. |
| Market Growth Drivers | Expansion fueled by personalized healthcare, biotech innovation, and global supplement adoption. |
The USA softgel capsules industry is rising consistently due to growing need for dietary supplements along with aging population and growing preference for easy-to-swallow dosage forms. Softgels are commonly used for vitamins, fish oils and prescription drugs, with very high consumer acceptance in OTC and pharmaceutical markets.
Innovation in ways to use gelatin alternatives, controlled-release technologies and bioavailability enhancement are also pepping up. Increased growth in the direct-to-consumer nutraceutical sector in addition to solid retail distribution are also factors in the expanding market.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 6.0% |
The UK softgel capsules market has been witnessing steady growth over the years, fueled by rising health consciousness among consumers, new opportunities in plant-based supplement trends, and advancements in functional nutrition. Softgels are the preferred form of omega-3, turmeric, and vitamin D supplementation, especially for joint health, immunity, and beauty applications.
To fulfil a gradually increasing customer base of vegetarians and halal consumers, brands are providing vegan and gelatine-free softgel choices. It is also a recommendation-driven market and e-commerce driven channel, with significant growth of personalized wellness products.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 5.5% |
The European Union softgel capsules market is poised for market expansion, driven by increased demand for high-absorption nutritional supplements, management of chronic diseases, and better regulation of nutritional products. It is due to this factor that Germany, Italy and the Netherlands is dominating in the production as well as consumption of nutraceutical and pharma-grade softgels.
As demand for clean-label, allergen-free and non-GMO supplements grows, softgel innovations, like plant-based and starch-based gel technologies, are also being developed by EU manufacturers. Because of higher bioavailability, pharmaceutical companies are utilizing softgels for hormone therapy, cardiovascular drugs, and central nervous system (CNS) treatments.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 5.8% |
Japan is experiencing moderate growth in its softgel capsules market, with the demand being led by its aging population, which prefers easy dosing formats and precise dosing, alongside a focus on wellness and health. Softgels are a popular delivery method in dosage forms that support eye health, energy, and cognitive function, and they are keenly focused on quality and efficacy.
At the same time, local pharmaceutical companies follow developments in customized softgel formulations for niche indications, and nutraceutical companies take advantage of their ability to combine coenzyme Q10 and lutein with collagen in softgel formats. Regulation promotes innovation and protects consumers.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.4% |
Growth of the South Korean softgel capsules market is thriving thanks to the wellness trends along with cosmetic-nutritional crossovers and tech-driven supplement delivery. Softgels for skin-care, weight management, and anti-fatigue formulations are gaining popularity among consumers, who are heavily swayed by beauty and wellness influencers.
And domestically, brands are launching sugar-free, fast-dissolving, and plant-based softgel capsules aimed at young, urban consumers. Healthcare segment growth is also being compounded by booming pharmaceutical demand for precision-dose softgels in oncology and chronic care.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.1% |
The global softgel capsules market are growing steadily with the increasing demand for the easy to swallow and nutraceutical, and cosmetic industries. Softgel capsules have many advantages compared to traditional tablets or hard capsules, especially when it comes to lipid-soluble drugs, herbal extracts and dietary supplements. Among the product types, the gelatin softgel capsules segment leads the market because of well-established manufacturing protocols, affordability, and extensive regulatory acceptance.
Based on raw material, Type-B gelatin segment is anticipated to have a dominance in the softgel capsules market due to its stability, which makes it appropriate for large scale softgel production. Collectively, these segments underlie the modern softgel market by simultaneously addressing efficacy, scalability, and consumer trust
Softgel formats also help them get the patient compliance along with aesthetic appeal they need, which is among the reasons why pharmaceutical companies and supplement manufacturers like them.
Offering proven performance, gelatin and animal-derived raw materials continues to fulfil industry demand with consumers worldwide craving fast-acting, easy-to-consume solutions. Despite the emergence of vegetarian capsule as an alternative, gelatin and its derivatives continue to dominate most regions and therapeutic categories.
| Product Type | Market Share (2025) |
|---|---|
| Gelatin Softgel Capsules | 64.7% |
At product segment, gelatin softgel capsules have captured the largest share of revenue generation, as they provide best combination of performance, flexibility and costs. These capsules are excellent vehicles for fat-soluble vitamins (A, D, E, and K), omega-3 oils, and complex formulations that necessitate a high bioavailability.
The gelatin shell dissolves rapidly in the gastrointestinal tract, leading to quick release and absorption of active ingredients. Gelatin is preferred by manufactures for its film-forming ability, relatively low reactivity, and compatibility with many formulations, which is why it is common across pharmaceutical, nutraceutical, and cosmeceutical domains.
They are also thought of as an easy-to-swallow, tasteless, and visually appealing option by consumers. These capsules back all prescription and over-the-counter (OTC) product lines from pain relief to sleep and multivitamins. The ability of gelatin capsule production to be scaled up or down helps companies to monitor costs while responding to high-volume demand, especially in developing economies where the pricing remains sensitive.
However, demand for gelatin softgels is likely to gain traction with rise in need for convenient and effective drug delivery systems which will keep gelatin softgels at the forefront in terms of the type of capsules in the global pharmaceutical market.
| Raw Material Type | Market Share (2025) |
|---|---|
| Type-B Gelatin (Animal Bones & Skin) | 52.3% |
Dominated the raw material segment is the Type-B gelatin, sourced from bovine bones and hides that exhibits high thermal stability, long gelling time, and good structural firmness. This gelatin type is chosen by manufacturers when producing softergels that need to be firmer for a longer shelf life.
Type-B gelatin is extracted through an alkaline treatment process that increases its resistance to degradation, and this type of gelatin is commonly found in softgels used for both medications and dietary supplements that require complicated manufacturing conditions. Its low cost and ready availability make it popular worldwide.
Because pharmaceutical companies need the regulatory approval that comes with Type-B gelatin in large areas like the USA, Europe, and Asia-Pacific. Its excellent mechanical properties guarantee capsules are not damaged during filling, packing, and transport.
Some consumer segments are now showing the desire for a plant-based option, however the vast majority of manufacturers are still opting for Type-B gelatin, as the hope to stick to the known parameters of capsule-forming quality prevails. Type-B gelatin will persist as the preferred raw material in the softgel market, given that industrial-scale production is critical for high-volume products such as over-the-counter (OTC) drugs and nutritional supplements.
The global softgel capsules products market enables consumers to attain a broad spectrum of physical and psychological wellness for longer and is one of the most promising and dynamic segments of the pharma industry. Softgels are popular not just for vitamins and supplements but omega-3s and prescription drugs as well, while providing protection to lipid-based and sensitive formulations.
Major players have their eyes set on gelatin and plant-based alternatives, high-throughput encapsulation, clean-label ingredients, and tailored release profiles. The market consists of CDMOs, pharma companies and dietary supplement manufacturers in therapeutic, preventive and wellness sectors worldwide.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Catalent, Inc. | 20-24% |
| Aenova Group | 15-19% |
| Sirio Pharma Co., Ltd. | 12-16% |
| BASF SE | 8-12% |
| Lonza Group Ltd. | 5-9% |
| Other Companies (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Catalent, Inc. | Introduced OptiGel ® DR delayed-release softgel technology for sensitive APIs in 2025, enhancing gastrointestinal protection and absorption. |
| Aenova Group | Launched vegan softgel capsule s lines with carrageenan and starch-based shells in 2024, targeting clean-label nutraceutical brands. |
| Sirio Pharma Co., Ltd. | Released gummy- softgel hybrid formats and mini softgels in 2025, offering high-dose delivery in compact, consumer-friendly designs. |
| BASF SE | Developed omega-3 enriched softgel ingredients with enhanced stability and shelf life in 2024, focused on cardiovascular and prenatal health markets. |
| Lonza Group Ltd. | Expanded Capsugel ® softgel portfolio to include plant-based and dual-fill systems in 2024, addressing multi-ingredient formulation needs. |
Key Company Insights
Catalent, Inc.
Catalent leads in pharma-grade softgel manufacturing, offering customized delivery platforms and proprietary technologies for prescription and OTC therapies.
Aenova Group
Aenova delivers high-volume softgel production, supporting nutritional and therapeutic product launches with an emphasis on vegan and allergen-free formats.
Sirio Pharma Co., Ltd.
Sirio focuses on innovation in consumer appeal, developing flavored, chewable, and mini softgels for global supplement brands targeting convenience and compliance.
BASF SE
BASF offers science-backed ingredients for softgel formulations, including stabilized omega-3s and bioactive lipids used in targeted health solutions.
Lonza Group Ltd.
Lonza is known for its Capsugel® innovations, providing plant-based, dual-action, and high-potency capsule systems tailored for therapeutic and wellness applications.
Other Key Players (30-40% Combined)
Several other companies contribute to the softgel capsules market, focusing on contract manufacturing, therapeutic category expansion, and plant-derived materials:
The overall market size for the softgel capsules market was USD 1,235.9 million in 2025.
The softgel capsules market is expected to reach USD 2,172 million in 2035.
The increasing demand for easy-to-swallow drug delivery forms, rising adoption in nutraceuticals and pharmaceuticals, and growing use of gelatin-based softgels, especially type-B gelatin, fuel the softgel capsules market during the forecast period.
The top 5 countries driving the development of the softgel capsules market are the USA, UK, European Union, Japan, and South Korea.
Gelatin-based softgels and type-B gelatin lead market growth to command a significant share over the assessment period.
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Cardiovascular Diagnostics Market Report- Trends & Innovations 2025 to 2035
Cold Relief Roll-On Market Analysis by Application, Distribution Channel, and Region through 2035
At-Home Micronutrient Testing Industry Share, Size, and Forecast 2025 to 2035
Bleeding Control Tablets Market Analysis - Growth, Applications & Outlook 2025 to 2035
Softgel Capsules Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
